Cardiovascular and metabolic screening: Blood pressure, cholesterol, blood sugar, and kidney function may be relevant depending on which medication is being considered
They were involved in evaluating the severity of their symptoms along with the treating physicians consultation which affected the choice to discontinue the drug or continue using it and treating the symptoms
A lack of education and resources, taken alongside a generally lower level of baseline strength in older females compared to males, may deter females from initiating participation in RT programs and further promote the age-related loss in muscle and physical independence that disproportionately affects older females (de Jong et al., 2023)
Evaluation of Silymarin for management of anti-tuberculosis drug induced liver injury: a randomized clinical trial
For people with a history of dieting or disordered eating, however, reduced appetite may also raise concerns about maintaining adequate nutrition or navigating past challenges with food

Contact your healthcare provider within 24 hours for: New or worsening abdominal discomfort that is persistent but not severe Unexplained nausea or changes in appetite beyond typical medication side effects Questions about your risk factors for pancreatitis Concerns about medication interactions or other health changes Schedule routine follow-up to discuss: Expected gastrointestinal side effects (nausea, diarrhea, constipation) that are common with tirzepatide but typically improve over time Weight loss progress and metabolic parameter monitoring Dose adjustments based on efficacy and tolerability Any new medications or supplements you're considering Patients with known risk factors for pancreatitisincluding history of gallstones, elevated triglycerides, or prior pancreatitisshould have more frequent monitoring and lower thresholds for evaluation of abdominal symptoms